Skip to content

Clinical trials

Lymphoma, Follicular trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Follicular Country / region: Canada Clear all

124 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20012
20023
20031
20041
20052
20063
20077
20082
20091
20105
20116
20127
201310
20144
20154
20165
20172
20185
20194
20205
20215
20227
20236
20246
20256
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed63
Active, not recruiting23
Terminated16
Recruiting12
Unknown status6
Withdrawn2
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer9
National Cancer Institute (NCI)7
Novartis Pharmaceuticals6
AstraZeneca4
Kythera Biopharmaceuticals4
NCIC Clinical Trials Group4
Sunnybrook Health Sciences Centre4
AbbVie3
Alliance for Clinical Trials in Oncology3
Amgen3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Follicular124
Lymphoma, Non-Hodgkin37
Lymphoma, Large B-Cell, Diffuse32
Lymphoma, Mantle-Cell30
Lymphoma, B-Cell, Marginal Zone28
Lymphoma25
Leukemia, Lymphocytic, Chronic, B-Cell24
Burkitt Lymphoma16
Waldenstrom Macroglobulinemia16
Lymphoma, Large-Cell, Immunoblastic15

Trials

Showing 51 to 75 of 124. Each trial links to its page on Pharma Observatory.

24 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.